Key Insights

Highlights

Success Rate

88% trial completion (above average)

Published Results

15 trials with published results (27%)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

7.1%

4 terminated out of 56 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

46%

26 trials in Phase 3/4

Results Transparency

54%

15 of 28 completed with results

Key Signals

15 with results88% success

Data Visualizations

Phase Distribution

42Total
Not Applicable (14)
P 1 (1)
P 2 (1)
P 3 (17)
P 4 (9)

Trial Status

Completed28
Unknown12
Recruiting6
Terminated4
Not Yet Recruiting3
Active Not Recruiting2

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 28 completed trials

Clinical Trials (56)

Showing 20 of 20 trials
NCT07326722Not ApplicableRecruitingPrimary

Delivering tAN to Reduce HMB: The LUNA Study

NCT07457957Not ApplicableNot Yet Recruiting

Effectiveness of an mHealth Innovation on the Impact of Menstrual Complaints in Adolescents

NCT06671548Phase 3RecruitingPrimary

Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

NCT05685199Terminated

Identifying the Determinants of Bleeding and Hypermobility in Patients With Heavy Menstrual Bleeding

NCT05916469RecruitingPrimary

Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study

NCT05922657RecruitingPrimary

A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device

NCT07267611Not Yet RecruitingPrimary

Evaluating the Reliability and Validity of the Arabic Version of the SAMANTA Questionnaire: A Step Toward Improved Diagnosis of Heavy Menstrual Bleeding

NCT06634719Not ApplicableRecruitingPrimary

Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)

NCT06814028Not ApplicableCompletedPrimary

Transcutaneous Auricular Neurostimulation as a Treatment for Women With Heavy Menstrual Bleeding: A Dose-finding Trial

NCT03271489Phase 3CompletedPrimary

Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

NCT06122363Active Not RecruitingPrimary

Impact of Incomplete Endometrial Ablation

NCT06064851Not ApplicableCompleted

Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Patients With and Without Von Willebrand Disease

NCT06921629Active Not Recruiting

Menstrual Complaints in Adolescents and Adults

NCT06740929RecruitingPrimary

Hormonal Management of Heavy Menstrual Bleeding in Adolescents

NCT04267562Not ApplicableCompleted

Minitouch Endometrial Ablation System Treatment for Menorrhagia: An Evaluation of Safety & Effectiveness

NCT04477837CompletedPrimary

Prospective Comparison of Incidence of Heavy Menstrual Bleeding in Women Treated With Direct Oral Anticoagulants

NCT06452342Phase 4Not Yet Recruiting

TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study

NCT03412890Phase 3CompletedPrimary

LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

NCT04205266Phase 4Unknown

IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding

NCT05606146Not ApplicableUnknownPrimary

IUB SEAD RED (Revolutionary Endometrial Ablation Device Study)

Scroll to load more

Research Network

Activity Timeline